How would you manage a patient with PV or ET who is experiencing breakthrough thrombosis?
For example, a patient on cytoreductive therapy and aspirin BID, but suffers an arterial event, or a patient who is already on therapeutic anticoagulation and has a recurrent VTE?
Answer from: at Academic Institution
The first question I would ask in this clinical situation is, "does the patient have PV or ET?"; a patient cannot have both. Unfortunately, I encounter this situation too often in my clinical practice. There appears to be a curious but dangerous belief in the medical community that ET is a more sero...
Comments
Medical Oncologist at Texas Oncology-San Antonio Babcock Dr. @Jerry Spivak, I truly enjoyed reading this an...
Medical Oncologist at Locum Tenens Wow. Amazing review and insight.
Thank you!
Medical Oncologist at Presbyterian Healthcare Services Thank you, Dr. @Jerry Spivak!
Can you comment on ...
at University of Washington School of Medicine Dr. @Jerry Spivak addresses phlebotomy in sec...
Regardless of the underlying condition, such as either ET or PV in this example, my approach is similar to that described by Dr. Sam Schulman in this excellent review in the Blood "How I Treat Series" on recurrent VTE.The primary question I think of is, "Why did prophylaxis fail and can I use this i...
Dr. @Jerry Spivak, I truly enjoyed reading this an...
Wow. Amazing review and insight. Thank you!
Thank you, Dr. @Jerry Spivak! Can you comment on ...
Dr. @Jerry Spivak addresses phlebotomy in sec...